ARTICLE | Clinical News
Voclosporin regulatory update
April 13, 2017 3:46 PM UTC
Aurinia said it believes results from the planned Phase III AURORA trial and the completed Phase IIb AURA-LV trial of voclosporin will be sufficient for regulatory submissions of the product in the EU...
BCIQ Company Profiles
BCIQ Target Profiles